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However, in a small subpopulation without evidence of myositis, the diagnosis may be critically delayed, hindering management of this rapidly progressive disease.
A 58-year-old Caucasian man presented with polyarthritis involving bilateral knees, shoulders, wrists and hand joints. He reported a history of questionable asthma with progressive dyspnoea despite optimal therapy. Examination revealed coarse pulmonary crepitations and diffuse small-joint swelling with rhagadiform skin changes over hands ( figure 1 ). Laboratory studies demonstrated leucocytosis and modest creatinine kinase elevation. Pulmonary function tests showed forced expiratory volume in 1 s/ forced vital capacity (FEV 1 /FVC) 76%, diffusing capacity of the lungs for carbon monoxide (DLCO) 63%, FEV 1 1.99 L (54%) with 9% (230 mL) reversibility with β-agonists, consistent with restrictive lung disease. High-resolution CT of the chest noted diffuse septal thickening and honeycombing (figures 2 and 3). Inflammatory arthritis, hyperkeratotic 'mechanic' hands and ILD prompted a diagnosis of ASS, confirmed by serum anti-Jo1 antibodies, despite the absence of clinical myositis. The patient improved on prednisone and methotrexate, and was later transitioned to mycophenolate mofetil.
Only 2-11% patients with ASS present with ILD in the absence of myositis and are diagnosed with anti-Jo1 antibodies in the serum. 2 Median interval of development of myositis after ILD is 6 months; however rarely extending up to 2 years. 1-3 Anti-Jo1 antibody-positive ILDs cause only modest serum creatine phosphokinase elevation that delays diagnosis in the absence of clinical myositis. 1 These patients deteriorate faster in comparison to patients with myositis. However, once diagnosed, they have high steroid-responsiveness, which is postulated to be due to higher non-specific interstitial pneumonia without manifest alveolar damage. 
